Streetbeat News

IVP

Inspire Veterinary Partners, Inc.

https://inspirevet.com

Industry

Personal Products & Services

Inspire Veterinary Partners, Inc. owns and operates veterinary hospitals in the United States. The company specializes in small animal general practice hospitals, which serve companion pets, canine, and feline breeds. Its hospitals provide preventive care for companion animals consisting of annual health exams and parasite control; dental health; nutrition and body condition counseling; neurological examinations; radiology; bloodwork; and skin and coat health, and other breed specific preventive care services. The company also provides surgical services, which include soft tissue procedures, such as spays and neuters, mass removals, splenectomies, gastropexies, orthopedic procedures, and other surgical offerings; and care and alternative procedures, such as acupuncture, chiropractic, and other health and wellness services. Inspire Veterinary Partners, Inc. was incorporated in 2020 and is based in Virginia Beach, Virginia.

Open

0.26

Mkt cap

6.5M

Volume

3.5M

High

0.27

P/E Ratio

-0.07

52-wk high

90.00

Low

0.24

Div yield

N/A

52-wk low

0.23

In Friday's after-market session, several healthcare stocks experienced significant movements. Palisade Bio (PALI) saw a 66% increase, while Aptorum Gr (APM) rose by 18.88%. NovaBay Pharmaceuticals (NBY), MyMD Pharmaceuticals (MYMD), NuCana (NCNA), and Asensus Surgical (ASXC) also posted gains. Conversely, Acutus Medical (AFIB), Aclarion (ACON), Inspire Veterinary (IVP), HeartBeam (BEAT), Panbela Therapeutics (PBLA), and AquaBounty Techs (AQB) experienced declines.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 9:31 pm

In Friday's intraday session, several healthcare stocks experienced significant movements. Corbus Pharmaceuticals (CRBP) saw a massive increase of 309.1%, while Aclarion (ACON) rose by 67.82%. Inspire Veterinary (IVP), Panbela Therapeutics (PBLA), Inhibikase Therapeutics (IKT), and Vera Therapeutics (VERA) also posted gains. Conversely, Onconetix (ONCO), Processa Pharma (PCSA), Evaxion Biotech (EVAX), Jin Medical International (ZJYL), Acutus Medical (AFIB), and TC BioPharm (TCBP) experienced declines, with ONCO leading the losses at 33.7%.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 5:31 pm

U.S. stocks were mixed in Friday's morning trading session after the release of PCE price inflation data for December. The Dow was slightly up, while the NASDAQ and S&P 500 saw minor declines. Health care shares were up by 0.5%, whereas information technology shares dropped by 0.8%. The PCE annual inflation rate remained steady at 2.6%, aligning with expectations. Inspire Veterinary Partners, Corbus Pharmaceuticals, and Aclarion saw significant share price increases, while Yoshitsu, Richtech Robotics, and Onconetix experienced notable declines. Oil prices fell slightly, while gold and silver saw modest gains.

Portfolio Pulse from Avi Kapoor

January 26, 2024 | 3:02 pm

In Friday's pre-market session, several healthcare stocks experienced significant movements. Inspire Veterinary (IVP) saw a 178.9% increase, Aclarion (ACON) rose by 115.01%, and Panbela Therapeutics (PBLA) went up by 61.23%. Conversely, Onconetix (ONCO) dropped by 32.8%, Jin Medical International (ZJYL) fell by 18.52%, and Passage Bio (PASG) declined by 11.09%. Other notable movements included gains for Corbus Pharmaceuticals (CRBP), NeuBase Therapeutics (NBSE), and Ainos (AIMD), and losses for PTC Therapeutics (PTCT), Aravive (ARAV), and Sagimet Biosciences (SGMT).

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 1:06 pm

Tellurian Inc. (NASDAQ:TELL) shares surged over 16% in pre-market trading on reports of hiring Lazard for a potential sale. Other stocks showed significant movement in pre-market trading, with various gainers and losers listed, including notable declines in Intel Corporation (NASDAQ:INTC) after a weak Q1 forecast, and Western Digital Corporation (NASDAQ:WDC) despite better-than-expected earnings.

Portfolio Pulse from Avi Kapoor

January 26, 2024 | 12:58 pm

In Thursday's after-market session, several healthcare stocks experienced significant movements. Inspire Veterinary (IVP) led the gainers with a 37.5% increase, while Processa Pharma (PCSA) saw the largest decline among the losers with a 14.7% drop. CVRx (CVRX) reported Q4 earnings, which may have influenced its 13.53% fall. The movements reflect changes in market capitalization for these companies, with impacts varying from $1.3 million to $1.7 billion.

Portfolio Pulse from Benzinga Insights

January 25, 2024 | 9:31 pm

RxSight, Inc. (RXST) shares surged by 20% after providing FY23 and FY24 revenue guidance above estimates and following a price target increase by Needham. Other stocks experienced significant movement, with Harpoon Therapeutics, Inc. (HARP) and Ambrx Biopharma Inc. (AMAM) seeing major gains due to acquisition announcements. Conversely, LumiraDx Limited (LMDX) and Solo Brands, Inc. (DTC) faced steep declines, with LumiraDx facing Nasdaq suspension and Solo Brands lowering its full year 2023 revenue guidance.

Portfolio Pulse from Avi Kapoor

January 08, 2024 | 6:36 pm

Health care stocks experienced significant movement in Monday's intraday session. Harpoon Therapeutics (HARP) saw a 112.4% increase, while LumiraDx (LMDX) dropped by 45.6%. Other notable gainers include Ambrx Biopharma (AMAM), Nkarta (NKTX), Universe Pharmaceuticals (UPC), Elevation Oncology (ELEV), and Venus Concept (VERO). On the losing side, Revance Therapeutics (RVNC), Prothena Corp (PRTA), Inspire Veterinary (IVP), Pacific Biosciences (PACB), and Jin Medical International (ZJYL) saw declines.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 5:31 pm

During Friday's intraday session, several healthcare stocks experienced significant movements. Ainos (AIMD) led the gainers with a 74.0% increase, while Mesoblast (MESO) saw the largest decline among the losers, dropping 50.0%. Other notable gainers include Elevation Oncology (ELEV), Alaunos Therapeutics (TCRT), Axogen (AXGN), NexImmune (NEXI), and Inovio Pharmaceuticals (INO). On the losing side, Applied Therapeutics (APLT), Avenue Therapeutics (ATXI), Inspire Veterinary (IVP), Agilon Health (AGL), and Omega Therapeutics (OMGA) also saw significant drops in their stock prices.

Portfolio Pulse from Benzinga Insights

January 05, 2024 | 5:31 pm

Inspire Veterinary Partners' stock is trading lower following the filing of a prospectus for a public offering of up to $5 million.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 5:27 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.